Receptor Activator of NF-κB (RANK) Ligand Induces Ectodomain Shedding of RANK in Murine RAW264.7 Macrophages-Reference-Cited by-同舟云学术

Receptor Activator of NF-κB (RANK) Ligand Induces Ectodomain Shedding of RANK in Murine RAW264.7 Macrophages

Published:2010-01-29 Issue:5 Volume:184 Page:2442-2448
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Hakozaki Akihiro,Yoda Masaki,Tohmonda Takahide,Furukawa Mitsuru,Hikata Tomohiro,Uchikawa Shinichi,Takaishi Hironari,Matsumoto Morio,Chiba Kazuhiro,Horiuchi Keisuke,Toyama Yoshiaki

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference37 articles.

1. The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling

2. Osteoclast differentiation and activation

3. The molecular understanding of osteoclast differentiation

4. RANKL–RANK signaling in osteoclastogenesis and bone disease

5. Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Downregulation of the metalloproteinases ADAM10 or ADAM17 promotes osteoclast differentiation;Cell Communication and Signaling;2024-06-11

2. Potential Immunomodulatory Role of Lead in Monocyte/Macrophage Differentiation;2023-04-05

3. Role of ADAM10 and ADAM17 in Regulating CD137 Function;International Journal of Molecular Sciences;2021-03-08

4. A novel modified RANKL variant can prevent osteoporosis by acting as a vaccine and an inhibitor;Clinical and Translational Medicine;2021-03

5. Unbalanced Vitreous Levels of Osteoprotegerin, RANKL, RANK, and TRAIL in Proliferative Diabetic Retinopathy;Ocular Immunology and Inflammation;2017-09-15